Vanda Pharmaceuticals
VNDA
#8772
Rank
A$0.33 B
Marketcap
A$5.51
Share price
-2.13%
Change (1 day)
-30.46%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total debt

Total debt on the balance sheet as of June 2026 : A$34.26 Million

According to Vanda Pharmaceuticals's latest financial reports the company's total debt is A$34.26 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Vanda Pharmaceuticals - Total debt on balance sheet (from 2005 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$18.84 M-5.17%
2024-12-31A$19.87 M43.96%
2023-12-31A$13.8 M-15.69%
2022-12-31A$16.37 M-4.02%
2021-12-31A$17.05 M-3.66%
2020-12-31A$17.7 M-15.11%
2019-12-31A$20.85 M
2018-12-31N/A
2005-12-31A$0.19 M-58.91%
2004-12-31A$0.47 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$67.00 B 195,463.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$72.49 B 211,489.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$94.82 B 276,678.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$74.28 B 216,714.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$80.89 B 235,998.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$67.24 B 196,159.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA